488 related articles for article (PubMed ID: 36334764)
1. Effects of prenatal opioid exposure on synaptic adaptations and behaviors across development.
Simmons SC; Grecco GG; Atwood BK; Nugent FS
Neuropharmacology; 2023 Jan; 222():109312. PubMed ID: 36334764
[TBL] [Abstract][Full Text] [Related]
2. Prenatal Opioid Exposure Enhances Responsiveness to Future Drug Reward and Alters Sensitivity to Pain: A Review of Preclinical Models and Contributing Mechanisms.
Grecco GG; Atwood BK
eNeuro; 2020; 7(6):. PubMed ID: 33060181
[TBL] [Abstract][Full Text] [Related]
3. Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.
Abu Y; Roy S
Exp Neurol; 2021 May; 339():113621. PubMed ID: 33516730
[TBL] [Abstract][Full Text] [Related]
4. Prenatal Opioid Exposure and Immune-Related Conditions in Children.
Kelty E; Rae K; Jantzie LL; Wyrwoll CS; Preen DB
JAMA Netw Open; 2024 Jan; 7(1):e2351933. PubMed ID: 38231512
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis.
Yeoh SL; Eastwood J; Wright IM; Morton R; Melhuish E; Ward M; Oei JL
JAMA Netw Open; 2019 Jul; 2(7):e197025. PubMed ID: 31298718
[TBL] [Abstract][Full Text] [Related]
6. Prenatal opioid exposure and well-child care in the first 2 years of life: population-based cohort study.
Camden A; To T; Gomes T; Ray J; Bai L; Guttmann A
Arch Dis Child; 2023 Sep; 108(9):754-761. PubMed ID: 37308290
[TBL] [Abstract][Full Text] [Related]
7. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
Elife; 2021 Mar; 10():. PubMed ID: 33724184
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to polycyclic aromatic hydrocarbons modifies the effects of early life stress on attention and Thought Problems in late childhood.
Pagliaccio D; Herbstman JB; Perera F; Tang D; Goldsmith J; Peterson BS; Rauh V; Margolis AE
J Child Psychol Psychiatry; 2020 Nov; 61(11):1253-1265. PubMed ID: 31907931
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging in infants with prenatal opioid exposure: Current evidence, recent developments and targets for future research.
Radhakrishnan R; Grecco G; Stolze K; Atwood B; Jennings SG; Lien IZ; Saykin AJ; Sadhasivam S
J Neuroradiol; 2021 Mar; 48(2):112-120. PubMed ID: 33065196
[TBL] [Abstract][Full Text] [Related]
10. Identification of Prenatal Opioid Exposure Within Health Administrative Databases.
Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33376211
[TBL] [Abstract][Full Text] [Related]
11. Early life stress alters opioid receptor mRNA levels within the nucleus accumbens in a sex-dependent manner.
Chang L; Kigar SL; Ho JH; Cuarenta A; Gunderson HC; Baldo BA; Bakshi VP; Auger AP
Brain Res; 2019 May; 1710():102-108. PubMed ID: 30594547
[TBL] [Abstract][Full Text] [Related]
12. Thalamocortical functional connectivity in infants with prenatal opioid exposure correlates with severity of neonatal opioid withdrawal syndrome.
Radhakrishnan R; Vishnubhotla RV; Guckien Z; Zhao Y; Sokol GM; Haas DM; Sadhasivam S
Neuroradiology; 2022 Aug; 64(8):1649-1659. PubMed ID: 35410397
[TBL] [Abstract][Full Text] [Related]
13. Differential Patterns of Synaptic Plasticity in the Nucleus Accumbens Caused by Continuous and Interrupted Morphine Exposure.
Lefevre EM; Gauthier EA; Bystrom LL; Scheunemann J; Rothwell PE
J Neurosci; 2023 Jan; 43(2):308-318. PubMed ID: 36396404
[TBL] [Abstract][Full Text] [Related]
14. Opioid withdrawal: role in addiction and neural mechanisms.
Monroe SC; Radke AK
Psychopharmacology (Berl); 2023 Jul; 240(7):1417-1433. PubMed ID: 37162529
[TBL] [Abstract][Full Text] [Related]
15. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Chalhoub RM; Kalivas PW
Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
[TBL] [Abstract][Full Text] [Related]
16. Early Identification of Atypical Motor Performance of Infants With Prenatal Opioid Exposure.
Boynewicz K; Campbell SK; Chroust A
Pediatr Phys Ther; 2023 Jul; 35(3):359-365. PubMed ID: 37126798
[TBL] [Abstract][Full Text] [Related]
17. Neural circuits controlling choice behavior in opioid addiction.
Chang VN; Peters J
Neuropharmacology; 2023 Mar; 226():109407. PubMed ID: 36592884
[TBL] [Abstract][Full Text] [Related]
18. Investigating the neurobiology of maternal opioid use disorder and prenatal opioid exposure using brain organoid technology.
Dwivedi I; Haddad GG
Front Cell Neurosci; 2024; 18():1403326. PubMed ID: 38812788
[TBL] [Abstract][Full Text] [Related]
19. Diagnoses during the First Three Years of Life for Children with Prenatal Opioid Exposure and Neonatal Abstinence Syndrome Using a Large Maternal Infant Data Hub.
Arter S; Lambert J; Brokman A; Fall N
J Pediatr Nurs; 2021; 61():34-39. PubMed ID: 33743318
[TBL] [Abstract][Full Text] [Related]
20. Opioid modulation of prefrontal cortex cells and circuits.
Cole RH; Moussawi K; Joffe ME
Neuropharmacology; 2024 May; 248():109891. PubMed ID: 38417545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
